Skip to Content Facebook Feature Image

HKUST Alumni Launch Vulnify: A Revolutionary Cybersecurity Service with Advanced Deepfake Fraud Detection to Combat Global Security Threats

TECH

HKUST Alumni Launch Vulnify: A Revolutionary Cybersecurity Service with Advanced Deepfake Fraud Detection to Combat Global Security Threats
TECH

TECH

HKUST Alumni Launch Vulnify: A Revolutionary Cybersecurity Service with Advanced Deepfake Fraud Detection to Combat Global Security Threats

2025-03-28 11:23 Last Updated At:12:20

Addressing the rapid increase in cybersecurity threats globally, ANTEI AI Development Hub, led by HKUST alumni and headquartered in Hong Kong, today proudly launched Vulnify.

This pioneering service and dynamic platform are specifically designed to empower businesses by proactively countering emerging cyber threats with advanced, AI-enhanced solutions.

Navigating the Cybersecurity Terrain in the Swift-paced AI Era

The rapid acceleration of application and platform development by using AI tools, has significantly increased the risk of cybersecurity vulnerabilities. Often, the swift pace of innovation overshadows the critical need for robust security measures, leaving businesses vulnerable to sophisticated cyber attacks.

Vulnify is poised to bridge this critical gap with rapid, comprehensive security audits conducted by elite cybersecurity professionals. By swiftly identifying and addressing vulnerabilities, Vulnify not only outlines potential security gaps but also provides detailed remediation strategies. Should complexities require specialized attention, Vulnify’s adept team stands ready to implement necessary safeguards, ensuring robust protection of client digital assets.

Revolutionizing Cybersecurity with Advanced AI Integration

Utilizing deep AI expertise, ANTEI AI Development Hub has meticulously crafted Vulnify to tackle the evolving complexities of cybersecurity. This platform transcends conventional security approaches by embedding AI to deliver proactive, tailored cybersecurity solutions. Each element of Vulnify is designed to meet the unique security needs of diverse business environments.

"Every business is unique, and their security solutions should be too. That's why our approach at Vulnify emphasizes customized defenses that align perfectly with our clients' specific operational and compliance needs," says Matey Yordanov, Group Managing Director of ANTEI AI Innovation Hub.

A Legacy of Innovation Driven by a Distinguished Alumni Network, HKUST

Vulnify's inception and success are bolstered by the profound insights and leadership of its founders—Matey Yordanov, Mikhail Bychkov, and Andrey Kuchma—all distinguished alumni of HKUST.

Their shared experience and educational foundation have been instrumental in shaping the strategic vision of Vulnify, ensuring a deep understanding of both technological and business challenges. Their university, HKUST, renowned for fostering innovative thinking and technological excellence, has been a significant influence in their commitment to advancing cybersecurity solutions.

Introducing Groundbreaking Deepfake Fraud Detection Capabilities

Building on its innovative streak, ANTEI AI Innovation Hub is proud to announce a significant breakthrough in combating digital fraud with its upcoming deepfake detection technologies. Following the immediate publication of their influential paper, "Cross-Technology Generalization in Synthesized Speech Detection: Evaluating AST Models With Modern Voice Generators," Vulnify is set to launch its advanced deepfake detection products and services in coming months. These are specifically designed to protect businesses and consumers from the rapidly growing threat of deepfake fraud, which costs the global economy billions annually. This technology leverages sophisticated AI algorithms to detect and mitigate the complex challenges posed by manipulated audio and video, ensuring the authenticity and security of digital communications."Deepfake technology poses unprecedented challenges to the integrity of digital media, and our mission at ANTEI is to arm businesses and consumers with the tools to detect and combat these sophisticated threats. Our deepfake detection technology is a critical part of our broader commitment to uphold digital truth and security," stated Andrey Kuchma, CEO of ANTEI AI Development Hub.

Vulnify’s Distinctive Features Include:

  • One-Click Cybersecurity Audit: Instantly scan entire digital infrastructures for over 100,000 vulnerabilities with a single click.

  • Customized Security Solutions: Adapted to meet stringent compliance and security requisites across multiple sectors, ensuring adherence to GDPR, CCPA, and ISO 27001.

  • Continuous Threat Intelligence: Leveraging real-time, global security data, Vulnify stays ahead of both existing and emerging cybersecurity threats.

  • Automated Recurring Scans: Schedule regular scans for all digital properties, maintaining continuous protection against new threats.

  • Audience-Specific Reporting: Generate customized reports geared towards various

stakeholders, including auditors, managers, developers, and investors, ensuring clarity and

actionable insights for each group.

A Commitment to Global Security Excellence

"Merging AI with cybersecurity is more than an innovation—it's a necessity in today's digital era," stated Mikhail Bychkov, CEO of Vulnify. "Vulnify embodies our commitment to using advanced AI to not only respond to but anticipate and neutralize cyber threats, ensuring uninterrupted and secure business operations worldwide."

ANTEI Limited invites industry partners, stakeholders, and the media to learn more about how its AI solutions are setting new standards in the industry.

About Vulnify

Vulnify is an advanced cybersecurity service and platform developed by ANTEI AI Development Hub, a leader in AI-driven technological solutions based in Hong Kong. As a proactive cybersecurity solution,

Vulnify is designed to empower businesses by safeguarding their digital landscapes against a broad spectrum of cyber threats, ensuring operational security and compliance with global standards. Learn more at www.vulnify.ai

About ANTEI AI Development Hub

Situated at the technological heart of Hong Kong, ANTEI AI Development Hub is a leader in transforming global industries through innovative AI solutions. With a commitment to innovation and excellence, ANTEI develops practical, cutting-edge AI tools that empower businesses of all scales to thrive securely in an increasingly digital world. Learn how ANTEI is shaping the future of AI innovation at https://anteihk.com

Executive Director of OASES visits Shanghai to foster I&T exchanges and encourage strategic enterprises' expansion in Hong Kong

The Executive Director of the Office for Attracting Strategic Enterprises (OASES), Mr Bryan Peng, and his team conducted a duty visit to Shanghai from November 17 to 18. During the visit, the OASES team engaged in in-depth discussions with leading and representative companies in the life and health technology sector. Their focus was on exploring diverse business development opportunities in Hong Kong and promoting the establishment of Hong Kong as a hub for health and medical innovation.

The Chief Executive's 2025 Policy Address clearly emphasises the importance of industry development and reform. Regarding the life and health technology industry, a key highlight is the establishment of the Hong Kong Centre for Medical Products Regulation by the end of 2026. Complementing this initiative is the new drug approval mechanism ("1+" mechanism) which facilitates pharmaceutical companies in accelerating the market launch of innovative drugs. Such policies provide strong support for companies to expand their businesses in Hong Kong and demonstrate the Government's commitment to becoming an international hub for health and medical innovation.

During the visit, Mr Peng and his team visited a pharmaceutical company ranked among the top ten in China's pharmaceutical industry. The company has established 6 R&D centres worldwide and 11 manufacturing sites. In discussions with the company's management, they shared a series of policies aimed at promoting Hong Kong as an international hub for health and medical innovation, including the establishment of the Greater Bay Area International Clinical Trial Institute which supports both local and international pharmaceutical research institutions and co-ordinates multi-centre clinical trials with cross-border research transformation, ensuring that these trials meet both national and international standards. The company's management recognised Hong Kong's unique advantages, including its high level of internationalisation and expertise in medical and research fields. They expressed their commitment to closely collaborate with OASES, actively utilising Hong Kong as a platform to advance their international innovation and R&D initiatives.

Subsequently, the team met with the management of a pharmaceutical company ranked among the top 50 globally and listed in Hong Kong. The company operates the largest research and production base for anti-tumour and surgical drugs in Chinese Mainland and is recognised as a highly innovative large-scale pharmaceutical company. The management expressed that the "1+" mechanism provides essential policy support for their products entering the Hong Kong market and affirmed the Government's investment and determination in the innovation and technology sector. Both parties agreed that Hong Kong, with its abundant high-end talent and international network, has become an important bridgehead for companies looking to expand globally. They also reached a consensus on advancing co-operation, including the establishment of overseas headquarter, research centre, corporate treasury centre, and drug registrations in Hong Kong.

The team also visited the Shanghai branch of an international pharmaceutical multinational cooperation, where the OASES team was invited to participate in their "Expert Talk" event, engaging with teams and research management experts from various regions worldwide. During the event, Mr Peng and the Chief Manager (Life and Health Technology) of the OASES,Dr Maggie Lo,provided a detailed introduction on Hong Kong's innovation and technology policies and dedicated support schemes in the life and health technology sector. This presentation generated widespread interest among the participating experts and company representatives. The OASES team will provide necessary support to relevant projects aimed at being implemented in Hong Kong.

Mr Peng remarked that the visit was highly fruitful. Through in-depth communication with industry leaders and representative companies, they effectively helped the companies gain a better understanding of Hong Kong's latest policies and provided critical insights for those looking to expand their global operations by leveraging Hong Kong's advantages as an innovation and technology hub. He emphasised that OASES is committed to attracting top international and Chinese Mainland pharmaceutical companies to establish operations in Hong Kong, in line with the key priorities outlined in the Chief Executive's 2025 Policy Address. Looking ahead, OASES will continue to expand its efforts and assist leading innovation and technology enterprises worldwide to establish in Hong Kong, further promoting the long-term development of the innovation and technology industry in Hong Kong.

Executive Director of OASES visits Shanghai to foster I&T exchanges and encourage strategic enterprises' expansion in Hong Kong  Source: HKSAR Government Press Releases

Executive Director of OASES visits Shanghai to foster I&T exchanges and encourage strategic enterprises' expansion in Hong Kong Source: HKSAR Government Press Releases

Executive Director of OASES visits Shanghai to foster I&T exchanges and encourage strategic enterprises' expansion in Hong Kong  Source: HKSAR Government Press Releases

Executive Director of OASES visits Shanghai to foster I&T exchanges and encourage strategic enterprises' expansion in Hong Kong Source: HKSAR Government Press Releases

Executive Director of OASES visits Shanghai to foster I&T exchanges and encourage strategic enterprises' expansion in Hong Kong  Source: HKSAR Government Press Releases

Executive Director of OASES visits Shanghai to foster I&T exchanges and encourage strategic enterprises' expansion in Hong Kong Source: HKSAR Government Press Releases

Executive Director of OASES visits Shanghai to foster I&T exchanges and encourage strategic enterprises' expansion in Hong Kong  Source: HKSAR Government Press Releases

Executive Director of OASES visits Shanghai to foster I&T exchanges and encourage strategic enterprises' expansion in Hong Kong Source: HKSAR Government Press Releases

Recommended Articles